The reaction of cyclopentanone with cyanoacetylhydrazine gave 2-cyano-2-cyclopentylideneacetohydrazide (1). Treatment of compound 1 with elemental sulphur in the presence of triethylamine afforded 2-amino-5,6-dihydro--4H-cyclopenta [b] thiophene-3-carbohydrazide (2) , which in-turn formed the corresponding intermediate diazonium salt. The latter was coupled with either ethyl cyanoacetate or ethyl acetoacetate to form 2-cyano-2-(3-(hydrazinecarbonyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)hydrazono)acetate (3) and ethyl 2-(2-(3-(hydrazinecarbonyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)hydrazono)-3-oxobutanoate (4), respectively. On the other hand, the reaction of compound 1 with either benzaldehyde or acetophenone afforded N'-benzylidene-2-cyano-2-cyclopentylideneacetohydrazide (7) and 2-cyano-2-(2-cyclopentylidene)phenylacetohydrazide (10), respectively. Moreover, compound 1 was used to synthesize 2-cyano-2-cyclopentylidene-N'-(arylthiazol-2(3H)-ylidene)acetohydrazides (6a,b), 2-(2-benzylidenecyclopentylidene)-2-cyanoacetohydrazide (8), 2-amino-N'-benzylidene-5,6-dihydro-4H--cyclopenta [b] thiophene-3-carbohydrazide (9), 2-cyano--2-(2-(2-phenylhydrazono)cyclopentylidene)acetohydrazide (11) , N'-(1-chloropropan-2-ylidene)-2-cyano-2-cyclopentylideneacetohydrazide (12) , and 2-cyclopentylidene-3--(3,5-disubstituted-1H-pyrazol-1-yl)-3-oxopropanenitriles (13a,b) through its reaction with the respective reagents. Antitumor evaluation of the newly synthesized compounds against the three human tumor cells lines, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268) showed that some of the described compounds exhibited higher inhibitory effects towards the three tumor cell lines than the reference compound doxorubicin.
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In many reports, hydrazide-hydrazones are considered to be good candidates for different pharmaceutical applications, where such compounds were considered as antibacterial, antifugal, antimicrobial and anticonvulsant agents (1) (2) (3) (4) (5) (6) (7) (8) . Moreover, many of them showed analgesic and antiplatelet properties. Therapeutic prominence of the hidrazide-hydrazone derivatives has been well established. In addition, hydrazide-hydrazones were reported to elicit anticancer (13) (14) (15) (16) (17) (18) (19) (20) and antiHIV properties (21) and hence they have gained an important place in medicinal chemistry. Recently, hydrazide-hydrazones have gained great importance due to their diverse biological properties, including anti-inflammatory, antimalarial and antituberculotic activities (22) (23) (24) (25) (26) (27) . With the aim of obtaining novel hydrazide-hydrazones with a wide spectrum of pharmaceutical applications, we report herein the synthesis of a series of hydrazide-hydrazones and some of their heterocyclic transformations, followed by antitumor evaluations of newly synthesized products (28, 29) .
EXPERIMENTAL
All melting points were determined on an electrothermal apparatus (Büchi 535, Switzerland) in an open capillary tube and are uncorrected. Elemental analyses were performed on a Yanaco CHNS Corder elemental analyzer (Japan). IR spectra (n, cm -1 ) were recorded in KBr pellets on a PA-9721 IR spectrophotometer (Shimadzu, Japan). 1 H NMR and 13 C NMR spectra were obtained on a Jeol 300 MHz (Japan) spectrometer in DMSO-d 6 as a solvent, using TMS as internal reference and chemical shifts (d) are expressed in ppm. Mass spectra were recorded on Kratos (75 eV) MS equipment (Germany). Synthetic pathways are presented in Schemes 1-3 and physicochemical and spectral data of the synthesized compounds are given in Tables I and II. Syntheses 2-Cyano-2-cyclopentylideneacetohydrazide (1) . -To a solution of cyanoacetylhydrazine (1.00 g, 0.01 mol) in 1,4-dioxane (30 mL) containing piperidine (0.50 mL), cyclopentanone (0.84 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 2 h and then left to cool. The solid product formed upon pouring onto ice/water containing a few drops of hydrochloric acid was collected by filtration.
2-Amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carbohydrazide (2)
. -A mixture of compound 1 (1.65 g, 0.01 mol) and elemental sulphur (0.32 g, 0.01 mol) in absolute ethanol (30 mL) containing triethylamine (0.80 mL) was heated under reflux for 2 h. The solid product formed upon pouring onto ice/water containing a few drops of hydrochloric acid was collected by filtration. (4) . General procedure. -A cold solution (0-5°C) of 1 (1.65 g, 0.01 mol) in acetic acid (10 mL) was added to a cold solution of nitrosyl sulphuric acid [prepared by the addition of sodium nitrite solution (0.7 g, 0.01 mol) to a cold solution of concentrated sulphuric acid (8 mL), then the resulting mixture was heated at 60°C for 1 h and then cooled to 0°C] under continuous stirring to form the appropriate diazonium sul-phate salt as yellow precipitate. The formed cold solution of the diazonium salt was added to a cold solution of either ethyl cyanoacetate (1.13 g, 0.01 mol) or ethyl acetoacetate (1.0 g, 0.01 mol) in ethanol (95 %, 40 mL) containing sodium acetate (4.0 g) under continuous stirring. The formed solid product, in each case, was collected by filtration.
2-(2-Cyano-2-cyclopentylideneacetyl)-N-phenylhydrazinecarbothioamide (5) . -To a solution of compound 1 (1.65 g, 0.01 mol) in absolute ethanol (40 mL) containing triethylamine (0.5 mL), phenylisothiocyanate (1.35 g, 9.91 mol) was added. The reaction mixture was heated under reflux in a boiling water bath for 3 h and then poured onto ice/water. The formed solid product was collected by filtration. was added. The reaction mixture was heated under reflux for 2 h and then poured onto water containing a few drops of sodium hydroxide solution (0.25 mL, 10 %). The formed solid product, in each case, was collected by filtration. N'-Benzylidene-2-cyano-2-cyclopentylideneacetohydrazide (7). -To a solution of comound 1 (1.65 g, 0.01 mol) in 1,4-dioxane (40 mL), benzaldehyde (1.06 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 2 h, then poured onto ice/water containing a few drops of hydrochloric acid and the formed solid product was collected by filtration.
2-Cyano-2-cyclopentylidene-N'-(4-methyl-3-phenylthiazol-2(3H)-ylidene)acetohydrazide (6a) and 2-cyano-2-cyclopentylidene-N'-(3,4-diphenylthiazol-2(3H)-ylidene)acetohydrazide (6b

2-(2-Benzylidenecyclopentylidene)-2-cyanoacetohydrazide (8)
-To a solution of compound 1 (1.65 g, 0.01 mol) in 1,4-dioxane (40 mL) containing piperidine (0.5 mL), benzaldehyde (1.06 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 2 h, then poured onto ice/water containing a few drops of hydrochloric acid and the formed solid product was collected by filtration.
2-Amino-N'-benzylidene-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carbohydrazide (9).
-To a solution of compound 7 (2.53 g, 0.01 mol) in 1,4-dioxane (40 mL) containing triethylamine (0.50 mL), elemental sulphur (0.32 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 1 h, then poured onto ice/water containing a few drops of hydrochloric acid and the formed solid product was collected by filtration.
2-Cyano-2-(2-cyclopentylidene)phenylacetohydrazide (10).
-To a solution of compound 1 (1.65 g, 0.01 mol) in 1,4-dioxane (40 mL), acetophenone (1.20 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 4 h, then left to cool overnight and the formed solid product was collected by filtration. N'-(1-chloropropan-2-ylidene)-2-cyano-2-cyclopentylideneacetohydrazide (12). -To a solution of compound 1 (1.65 g, 0.01 mol) in 1,4-dioxane (40 mL), a-chloroacetone (0.92 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 2 h, then left to cool overnight and the formed solid product was collected by filtration.
2-Cyano-2-(2-(2-phenylhydrazono)cyclopentylidene)acetohydrazide (11)
.
2-Cyclopentylidene-3-(3,5-diamino-1H-pyrazol-1-yl)-3-oxopropanenitrile (13a) and 3-(3--amino-5-hydroxy-1H-pyrazol-1-yl)-2-cyclopentylidene-3-oxopropanenitrile (13b). General pro-
cedure. -To a solution of compound 1 (1.65 g, 0.01 mol) in 1,4-dioxane (40 mL) containing triethylamine (0.50 mL), either malononitrile (0.66 g, 0.01 mol) or ethyl cyanoacetate (1.13 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 2 h, then poured onto ice/water containing a few drops of hydrochloric acid and the formed solid product was collected by filtration.
Antitumor screening
Fetal bovine serum (FBS) and L-glutamine were from Gibco Invitrogen Co. (UK). RPMI-1640 medium was from Cambrex (USA). Dimethyl sulfoxide (DMSO), doxorubicin, penicillin, streptomycin and sulforhodamine B (SRB) were from Sigma Chemical Co. (USA). Stock solutions of new compounds 1-13a,b (25 mmol L -1 ) were prepared in DMSO and kept at -20°C. Appropriate dilutions of the compounds were prepared just prior to the assays.
Cell cultures. -Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI--H460 (non-small cell lung cancer), and SF-268 (CNS cancer) were used. MCF-7 was obtained from the European Collection of Cell Cultures (Salisbury, UK) and NCI-H460 and SF-268 were kindly provided by the National Cancer Institute (Cairo, Egypt). They grew as monolayers and were routinely maintained in RPMI-1640 medium supplemented with 5 % heat inactivated FBS, 2 mmol L -1 glutamine and antibiotics (penicillin 100 mg mL -1 , streptomycin 100 mg mL -1 ), at 37°C in a humidified atmosphere containing 5 % CO 2 . Exponentially growing cells were obtained by plating 1.5 x 10 5 cell mL -1 for both of MCF-7, SF-268 and 0.75 x 10 4 cell mL -1 for NCI-H460, followed by 24 h of incubation. The effect of the solvent (DMSO) on the growth of these cell lines was evaluated in all experiments by exposing untreated control cells to the maximum concentration (0.5 %) of DMSO used in each assay where doxorubicin was used as the reference compound.
Results are given in concentrations that were able to cause 50 % cell growth inhibition (GI 50 ) after a continuous exposure for 48 h ± SEM of three-independent experiments performed in duplicate.
RESULTS AND DISCUSSION
Chemistry
The reaction of cyanoacetylhydrazine with cyclopentanone using ammonium acetate gave the 2-cyano-2-cyclopentylideneacetohydrazide (1). The structure elucidation of the latter product was based on analytical and spectral data. Thus, the 1 H NMR spectrum showed the presence of two multiplets at d 1.17-2.34 ppm corresponding to the four CH 2 groups, a singlet at d 3.83 ppm corresponding to the NH 2 group and a singlet (D 2 O exchangeable) at d 8.54 ppm indicating the NH group. Moreover, its 13 The reaction of compound 1 with acetophenone in 1,4-dioxane gave the 2-cyano-2--(2-(2-cyclopentylidene)phenylacetohydrazide (10) . Moreover, the reaction of compound 1 with benzenediazonium chloride in the presence of sodium acetate at 0°C gave the 2-cyano-2-(2-(2-phenylhydrazono)cyclopentylidene)acetohydrazide (11) . On the other hand, the reaction of 1 with chloroacetone gave the N'-(1-chloropropan-2-ylidene)-2-cyano-2-cyclopentylideneacetohydrazide (12) . Finally, we moved towards studying the reactivity of compound 1 with cyanomethylene reagents with the aim of its heterocyclization to the potentially antitumor pyranoles. Thus, compound 1 reacted with either malononitrile or ethyl cyanoacetate to give the 2-cyclopentylidene-3-(3,5-disubstituted-1H-pyrazol-1-yl)-3-oxopropanenitriles 13a and 13b, respectively. The analytical and spectral data of 13a and 13b are in agreement with their respective structures.
Antitumor activity and structure activity relationship
The effect of compounds 1-13a,b was evaluated through the in vitro growth of three human tumor cell lines representing different tumor types, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268), after continuous exposure for 48 h. The results summarized in Table III showed that all the compounds were able to inhibit the growth of the human tumor cell lines in a dose-dependent manner. 2-Cyano-2-cyclophentylideneacetohydrazido-N-(4-cyano-3-phenyl-4-phenylthiazol-2-ylideno)-hydrazone (6b), 2-cyano-2-cyclopentylideneaceto-N-benzalhydrazide (7), 2-cyano-2-(2--(2-phenylhydrazono)cyclopentylidene)acetohydrazide (11) and 3-(3-amino-5-hydroxy-1H--pyrazol-1-yl)-2-cyclopentylidene-3-oxopropanenitrile (13b) showed the best results. It is 54
